• Fulgent Genetics — Investment Thesis

  • Nov 18 2024
  • Length: 35 mins
  • Podcast

Fulgent Genetics — Investment Thesis

Listen for free

View show details

  • Summary

  • In this episode, we dive deep into Fulgent Genetics ($FLGT) , an under-the-radar precision medicine company revolutionizing both genetic testing and drug development. Armed with a proprietary technology platform, deep cash reserves, and a proven management team, Fulgent is poised for transformational growth. We examine how Fulgent's efficient genetic testing business is gaining market share, expanding margins, and fueling a promising drug pipeline focused on hard-to-treat cancers. With a rock-solid balance sheet, accelerating core business, and optionality from its therapeutic endeavors, Fulgent represents a unique investment opportunity at the intersection of genetics and drug discovery. Got questions or feedback? Reach out to us at contactinvestorscompass@gmail.com.
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Fulgent Genetics — Investment Thesis

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available